Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Ghko B 2025 Sep 16, 16:00

Major Cryptos Updates: XRP VS DOGE, Which Crypto Has a Greater Potential?

crypto
Noah Lee 2025 Sep 16, 14:11

The Fed's Third Mandate: Is the Trump Administration Seeking to Influence Long-Term Interest Rates?

Sophia Claire 2025 Sep 16, 13:10

S&P 500 Sets New Highs: Jonathan Golub's Bullish Outlook Explained

Noah Lee 2025 Sep 16, 07:10

Moody's Economist Warns: Recession Risk Climbs to 'Uncomfortably High' Level

Ghko B 2025 Sep 15, 16:00

Trending ETF Comparison: Invesco QQQ Trust (QQQ), Vanguard S&P 500 ETF (VOO)

etfs stocks
Ghko B 2025 Sep 15, 16:00

NASDAQ: ATYR Stock Crashed Over 80%: What’s Happening with aTyr Pharma?

stocks
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Liam James 2025 Sep 16, 15:20

Treasury Secretary Defends Milan's Fed Appointment Amidst Controversy

Emma Rose 2025 Sep 16, 14:20

Fed Rate Cut Imminent: How Will the Market React?

Noah Lee 2025 Sep 16, 14:20

Gold Prices Reach Record Highs Amid Fed Easing Expectations

Ava Grace 2025 Sep 16, 13:20

Russian Oil Output Faces Cuts Amid Ukrainian Drone Strikes: Report

Sophia Claire 2025 Sep 16, 13:20

US Consumer Spending Defies Economic Concerns in August

Ava Grace 2025 Sep 16, 12:20

S&P 500 Hits Record Highs Amid Jobless Expansion: A Paradox?

Noah Lee 2025 Sep 16, 11:20

Gold Price Soars as Fed Rate Cut Expectations Mount: Reaching New Heights

Ava Grace 2025 Sep 16, 10:20

EU Delays Russia Sanctions Amid US Pressure & New G7 Plans

Info

Spread

0.29

Spread (%)

0.6284 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

94342643712

Shares Outstanding

2035440000

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-07-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0537

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 15, 16:00

How to Start PLTR Stock CFD Trading: AvaTrade, MT4, Pepperstone

Shares Stocks CFD Trading
Frances Wang 2025 Sep 15, 16:00

Tesla Inc (TSLA) Stock CFD Trading: Oanda, XTB, Plus500, markets.com

Stocks CFD Trading
Frances Wang 2025 Sep 15, 16:00

World Indices CFD Trading for Beginners: Dow Jones, DAX 30, Japan 225

Stocks Indices CFD Trading
Trustpilot